TC BioPharm Files 6-K Report
Ticker: TCBWF · Form: 6-K · Filed: Jul 29, 2024 · CIK: 1872812
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
TC BioPharm filed a 6-K, standard reporting for foreign issuers.
AI Summary
TC BioPharm (Holdings) plc filed a Form 6-K on July 29, 2024, reporting as a foreign private issuer. The company, previously known as TC BioPharm (Holdings) Ltd and TC BioPharm Ltd, is based in Holytown, Scotland, United Kingdom, and operates in the biological products sector.
Why It Matters
This filing indicates ongoing reporting requirements for TC BioPharm (Holdings) plc as a foreign private issuer, providing updates to the SEC.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- TC BioPharm (Holdings) plc (company) — Filer
- TC BioPharm (Holdings) Ltd (company) — Former company name
- TC BioPharm Ltd (company) — Former company name
- July 29, 2024 (date) — Filing date
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K filing is used by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have submitted or are required to submit to their home country's stock exchange.
What is TC BioPharm (Holdings) plc's industry classification?
TC BioPharm (Holdings) plc is classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' with SIC code 2836.
When was TC BioPharm (Holdings) plc previously known by other names?
The company was formerly known as TC BioPharm (Holdings) Ltd as of July 21, 2021, and TC BioPharm Ltd as of July 14, 2021.
Where is TC BioPharm (Holdings) plc's principal executive office located?
The principal executive offices are located at Maxim 1, 2 Parklands Way, Holytown, Motherwell, ML1 4WR, Scotland, United Kingdom.
Does TC BioPharm (Holdings) plc file annual reports under Form 20-F or 40-F?
TC BioPharm (Holdings) plc indicates it files annual reports under cover of Form 20-F.
Filing Stats: 550 words · 2 min read · ~2 pages · Grade level 12.5 · Accepted 2024-07-29 16:05:26
Filing Documents
- form6-k.htm (6-K) — 31KB
- 0001493152-24-029416.txt ( ) — 32KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TC BIOPHARM (HOLDINGS) PLC Date: July 29, 2024 By: /s/ Martin Thorp Martin Thorp Chief Financial Officer